Profile_bird

Hey there! NatRevDrugDisc is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving NatRevDrugDisc's tweets.

Already using Twitter
from your phone? Click here.

NatRevDrugDisc

  1. The FDA: A tough tonic http://ff.im/-c08we (RT @NatureNews)
  2. RT @NatureNews Bug-based flu vaccine rebuffed http://ff.im/-bLrm2
  3. RT @NatureNews Gene silencing predicted to improve drug manufacturing http://ff.im/-bIvYf
  4. RT @NatureNews HIV vaccine failure still an enigma http://ff.im/-bC67J
  5. Podcast from the journal Clinical Pharmacology and Therapeutics, produced in association with Nature Publishing Group http://bit.ly/6Gswq
  6. Genentech obtains proof of concept for hedgehog inhibition http://bit.ly/4qcEE8 (Nat Biotech, sub) early studies http://bit.ly/2vbsGq (free)
  7. Targeted sequencing of protein-coding genes finds cause of Miller syndrome, a rare genetic disorder http://bit.ly/MJUNz (via @NatureNews)
  8. Fresh hope for German stem-cell patent case http://ff.im/-byhZO (RT @NatureNews)
  9. Cholesterol drugs' effectiveness called into question — again http://ff.im/-byhZN (via @NatureNews)
  10. WHO guidelines presage US biosimilars legislation? http://bit.ly/MEiA6 (from Nature Biotech, sub required)
  11. Pfizer to close six research sites http://ff.im/-bfsaT (via @NatureNews)
  12. Faster route to stem-like cells http://ff.im/-b9NSs (via @NatureNews)
  13. Can literature analysis identify innovation drivers in drug discovery? http://bit.ly/2O6Be1
  14. Brain disease treated by gene therapy http://ff.im/-b2xhj (via @NatureNews)
  15. Antidepressant action through gene regulation http://bit.ly/ey5gI - histone deacetylase inhibitors have antidepressant actions
  16. Recent talk about cancer vaccines (Merck KGaAs's Stimuvax, Dendreon's Provenge and Accentia's BioVaxID) reminds me: http://bit.ly/E8ZAY
  17. #GSK and #Pfizer launched ViiV Healthcare to develop #HIV therapies. See our analysis of what they may develop @ http://bit.ly/3QZFtf
  18. Nanoparticle safety looking more complicated http://ff.im/-b2phZ (via @NatureNews)
  19. Dual benefit of bile acid receptor agonist http://bit.ly/4gqRoG possible new class of agents for the management of diabetes and obesity
  20. Reminder - Nature Reviews Drug Discovery news, highlights and featured article FREE to registered users